|
|
|
| |
News - Adventist Health System, Winter Park Florida USA |
|
|
|
|
|
|
| Adventist Health System |
| Adventist Health System Achieves Lower Incidence of Hypoglycemia with EndoTool |
| Date : - 01/07/2009 |
|
Adventist Health System (AHS) announced that it has achieved low system-wide hypoglycemia (low blood glucose) incidence rates comparable to those in the Normoglycemia in Intensive Care Evaluation -- Survival Using Algorithm Regulation (NICE-SUGAR) trial. The NICE-SUGAR study, published in the March 26 issue of the New England Journal of Medicine (NEJM), has raised the visibility of inpatient management of uncontrolled blood glucose levels. While the study suggests that intensive blood glucose control for critical care patients with hyperglycemia (high blood glucose) does not improve outcomes,AHS data supports a system-wide effort to provide good glucose control in diabetic and non-diabetic hyperglycemic patients
The percentage of patients on the EndoTool® glucose management system experiencing severe hypoglycemia (blood glucose levels = 40 mg/dL) across AHS in medical, surgical and mixed intensive care units (ICUs) for the last quarter of 2008 was 1.8%. Although the blood glucose treatment goals differed (100 – 150 mg/dL at AHS; 81 – 108 mg/dL for NICE-SUGAR), NICE-SUGAR reported that 6.8% of patients experienced severe hypoglycemia in the intensive control arm of the study. Adventist Health System believes this increased rate of hypoglycemia may be a reflection of the treatment protocol and methods used to control glucose levels.
"Controlling glycemic, or blood glucose, levels is a major challenge in ICUs so we set out to identify a solution to reduce the incidence and thereby the impact of uncontrolled glucose," said Paul R. Garrett, Jr., M.D., medical director, Evidenced Based Practice, Office of Clinical Effectiveness, AHS. "We believe computer-based protocols, like EndoTool, are the future of glycemic control, replacing paper-based systems that use broad target glucose ranges, as in the NICE-SUGAR study."
This single technology helps effectively manage widely diverse and complex medical needs, bringing a single standard of care in blood glucose management to patients admitted to AHS institutions. Of all blood glucose measurements in ICUs for patients managed with EndoTool at AHS during the fourth quarter of 2008, only 0.06% of all glucose measurements showed severe hypoglycemia (blood glucose levels = 40 mg/dL).
In acute and critical-care settings, effective blood glucose management is integral to highquality, safe patient care. Maintaining the appropriate precision to avoid under- or over-dosing of insulin is essential to improved patient management. Overly aggressive insulin therapy can increase the risk of hypoglycemia, an independent risk factor for mortalityi. |
|
| Reference : - www.adventisthealthsystem.com |
| Back To List |
|
|
|
|
|
| Copyright © 2024 Medical Tour Information All Rights Reserved |
|